Colinz Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE923C01011
  • NSEID:
  • BSEID: 531210
INR
76.02
-4 (-5.0%)
BSENSE

Feb 02

BSE+NSE Vol: 635

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Colinz Labs
Span Divergent
Desh Rakshak
Ishita Drugs
Shree Ganesh Bio
Zenith Health
ANG Lifesciences
Venmax Drugs
Starsource Multi
Medicamen Organ.
Mono Pharmacare

Why is Colinz Laboratories Ltd ?

1
Weak Long Term Fundamental Strength with a -1.13% CAGR growth in Net Sales over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.37
  • The company has been able to generate a Return on Equity (avg) of 4.90% signifying low profitability per unit of shareholders funds
2
Flat results in Dec 25
  • ROCE(HY) Lowest at 5.88%
3
With ROE of 5, it has a Expensive valuation with a 1.9 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 35.75%, its profits have fallen by 0% ; the PEG ratio of the company is 0.8
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Colinz Labs for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Colinz Labs
35.75%
0.49
72.58%
Sensex
5.37%
0.47
11.36%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-1.13%
EBIT Growth (5y)
3.01%
EBIT to Interest (avg)
0.37
Debt to EBITDA (avg)
0.63
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.75
Tax Ratio
16.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.95%
ROE (avg)
4.90%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
39
Industry P/E
32
Price to Book Value
1.94
EV to EBIT
12.39
EV to EBITDA
12.39
EV to Capital Employed
3.97
EV to Sales
2.12
PEG Ratio
0.76
Dividend Yield
NA
ROCE (Latest)
7.37%
ROE (Latest)
4.96%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-3What is not working for the Company
ROCE(HY)

Lowest at 5.88%

Loading Valuation Snapshot...